Spinosad Patent Expiration
Spinosad is used for treating scabies mite infestations and head lice infestations. It was first introduced by Cipher Pharmaceuticals Inc
Spinosad Patents
Given below is the list of patents protecting Spinosad, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Natroba | US9895388 | Methods and compositions useful for controlling cutaneous mites | Nov 25, 2033 | Cipher |
| Natroba | US7030095 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
Jul 02, 2021
(Expired) | Cipher |
| Natroba | US6063771 | Formulations for controlling human lice |
Jun 22, 2019
(Expired) | Cipher |
| Natroba | US6342482 | Formulations for controlling human lice |
Jun 22, 2019
(Expired) | Cipher |
| Natroba | US5496931 | Insecticide and miticide A83543 compounds and their method of production by fermentation |
Mar 05, 2013
(Expired) | Cipher |
Spinosad's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List